Cyclohex-1-enecarbaldehyde, 95.0%, 5g

Acide L(+)-ascorbique, min 99 %, pa, 250 g, emballage plastique.

2-amino-1-(4-(methylthio)phenyl)ethan-1-one hydrochloride, 95.0%, 2g

2,3-Difluoro-N,N-dimethylbenzamide, 95%, 1g

1-[2-(2-Hydroxyethoxy)ethyl]piperazine, 95.0%, 5g

3-Methylpyrrolidin-3-amine dihydrochloride, 98%, 250mg

1,2-Bis[(2S,5S)-2,5-diphenylphospholano]ethane(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate, 98%, 100mg

4-Bromocinnamic Acid>98.0%(GC)(T)25g

(2S,4R)-1-((S)-14-amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamidehydrochloride, 95%, 100mg

4-(Trifluoromethyl)cyclohexanol, cis/trans, 97.0%, 25g

2-(methoxymethyl)-5-methyl-1H-benzimidazole, 95.0%, 5g

3-(Phenylsulfonyl)propanoic acid, 97.0%, 1g

5-(difluoromethyl)-1,3,4-thiadiazol-2-amine, 95+%, 50g